$CRNT

Craig - Hallum Raises its Price Target on Ceragon Networks (CRNT)

On May 20, 2026, Craig-Hallum analyst Christian Schwab raised Ceragon Networks’ (CRNT) price target to $4 from $3 and kept a Buy rating, citing solid Q1 results and full-year revenue guidance of $355M–$385M. Roth Capital analyst Scott Searle raised its target to $4.50 from $3.75, also maintaining Buy. Ceragon reported Q1 non-GAAP EPS of 1c and revenue of $85.0M, above consensus, while noting margin pressure from costs and FX.

Original reporting
Published Jun 8, 2026, 7:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Craig - Hallum Raises its Price Target on Ceragon Networks (CRNT) — source image
Decision brief

The 30-second read

$CRNTBullishLow
01

Why it matters

Raised price targets and maintained Buy ratings can support sentiment, but the key risk highlighted is margin pressure and FX headwinds, which could cap upside if subsequent quarters show deterioration.

02

Market read

Street targets moved higher on reiterated revenue guidance after a Q1 beat, but the article’s incremental trading edge is limited because it is analyst-driven rather than a new company disclosure.

03

What to watch

The article emphasizes demand wins (E-band, FR2 progress, tier-1 North American carrier POC) but provides no new quantitative margin outlook; traders may need to watch gross margin and FX sensitivity for confirmation.

Relevance 7/10Novelty 4/10Timing: pre-market today (published 2026-06-08)

Background

The piece summarizes two analyst actions (Craig-Hallum and Roth Capital) following Ceragon’s Q1 results and maintained full-year revenue guidance.

Company-level read

Ticker impact

$CRNTBullishMedium confidence
Context

Craig-Hallum raised Ceragon’s price target to $4 from $3 and kept a Buy rating, citing solid Q1 results and reiterated FY revenue guidance of $355M-$385M.

Expected impact

Mildly positive bias for the stock as the Street digests the raised targets; follow-through depends on margin pressure and FX trends mentioned by management.

Evidence & confidence

The article is driven by two analyst price-target increases tied to specific, reiterated guidance and Q1 beats, but it does not introduce a new company event beyond the already-reported Q1.

Market effects

Positive read-through for wireless transport equipment names if investors view Ceragon’s demand signals (e.g., India, E-band) as durable despite margin/FX headwinds.

Highlights strength in India demand, which could modestly influence regional sentiment for telecom infrastructure spend.

Reiterated multi-region demand and carrier/POC progress may support broader confidence in global wireless transport capex cycles.

Counterpoint

Despite revenue guidance being maintained, management flags margin pressure from macro/industry cost increases and adverse FX—targets may be optimistic if profitability deteriorates.

Key entities

  • Ceragon Networks Ltd.

    Wireless transport solutions provider; subject of analyst target increases and Q1/guidance discussion.

  • Craig-Hallum (Christian Schwab)

    Raised price target to $4 from $3 and maintained Buy, citing solid Q1 and FY revenue guidance $355M-$385M.

  • Roth Capital (Scott Searle)

    Raised price target to $4.50 from $3.75 and maintained Buy, citing solid Q1 and guidance as a solid outcome.

  • Doron Arazi

    CEO quoted on healthy demand, India strength, E-band/FR2 progress, and margin/FX pressures.

Related articles

$CRNTMedAI 9/10

Ceragon Networks (CRNT) Is Banking on India to Make Up for a Slow Start to 2026

Ceragon Networks (NASDAQ:CRNT) reported Q1 2026 revenue of $85.0 million, down 4.1% year over year but above Wall Street’s $80.4 million consensus, according to the company. CEO Doron Arazi attributed the decline to timing of Indian operator orders converting to revenue. India accounted for 35% of revenue; management said it booked about $86 million in orders year-to-date, with ~$24 million recognized in Q1. Non-GAAP EPS was $0.01 vs $0.03 in Q1 2025; GAAP gross margin rose to 35.4%. CFO Ronen S

$SPCXMed

Why SpaceX Stock Just Gained 15.8%

Space Exploration Technologies Corp. (SpaceX, NASDAQ: SPCX) shares rose 15.8% on Friday, outperforming the S&P 500 and Nasdaq. The move followed the first tranche of an IPO lock-up expiring, with 911.5 million shares becoming eligible to trade, and a joint SpaceX and Tesla announcement of a $16.8 billion Texas Terafab semiconductor project.

$DOCSMed

Why Doximity Stock Skyrocketed on Friday

Doximity (NYSE: DOCS) shares rose after CEO Jeff Tangney said early returns from the company’s AI investments are improving profitability. In fiscal 2027 Q1 ended June 30, revenue increased 7% to $156.6M, while adjusted EBITDA fell 6% to $74.8M. Tangney cited >25% QoQ AI prompt volume growth and 10x AI Scribe users, plus revenue exceeding 10x search costs.